Although considerable evidence suggests that bronchopulmonary dysplasia (BPD) is the result of prolonged inflammation and impaired healing of the immature lung, the mediators that regulate inflammation in neonatal lung injury have not been completely elucidated. We examined whether the cytokines IL-6 and tumor necrosis factor-a (TNF) interact to modulate a cascade of cell-cell signaling events involved in inflammation contributing to the development of BPD. To determine the relative activities of these cytokines in neonatal lung injury, lung lavage samples were serially obtained from 1 to 28 d from 11 infants with self-limited respiratory distress syndrome (RDS), 19 infants with evolving BPD, and 10 control infants ventilated for nonpulmonary reasons. On the first day of life, there were no differences in antigenic IL-6 concentrations in lavage fluids among the BPD, RDS, and control groups, but IL-6 activity determined by the 7TD1 proliferation assay was 15-fold and 6.6-fold higher in lung lavage of infants who developed BPD compared with activities in lavage from control and RDS infants, respectively (control, Exogenous surfactant therapy has dramatically improved survival of very-low-birth-weight infants with RDS, but it has not affected the incidence of the neonatal chronic lung disorder B P D (1). This suggests that factors in addition t o surfactant deficiency contribute t o neonatal lung injury. Pathologic findings in B P D are consistent with a process of prolonged lung inflammation and impaired healing (2, 3). In human infants with RDS (4-6) 49 .4 ? 17.6; RDS, 117.3 2 59.6; BPD, 779.5 2 212.6 x 10' hybridoma units/L, mean * SEM,p = 0.02). This suggests that pathways for inactivating or inhibiting IL-6 that may be present in the lungs of RDS and control infants may be deficient in BPD infants. IL-6 activity remained elevated in lavage of BPD infants for the first 2 wk and declined to low levels by d 28. There were no differences among groups on the first day of life for TNF antigen concentration or TNF activity determined by the L929 bioassay. Detectable but low TNF activity was found in BPD samples, with peak activity found in d-14 samples. Differences in complex interactions among these and other cytokines with their receptors and inhibitors may predispose some infants with RDS to develop BPD. (Pediuh. Res 36: 244-252, 1994) Abbreviations RDS, respiratory distress syndrome BPD, bronchopulmonary dysplasia TNF, tumor necrosis factor-a PROM, prolonged rupture of membranes and in primate models of acute lung injury (7), there is a rapid influx of neutrophils into the lung during the first 48 t o 96 h after initial injury followed b y a n increase in alveolar macrophages with subsequent resolution of airw a y inflammation. In contrast, in infants w h o develop BPD, the neutrophil influx is prolonged and the alveolar macrophage entry is delayed and blunted (5). nolysis (13), the mediators that regulate neonatal lung
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IL-6 AND TNF-a IN INFANT LUNG LAVAGE
245 injury in patients with BPD have not been completely elucidated. There is now considerable experimental evidence that the inflammatory cascade initiated by acute injury in the adult lung is mediated by the release of cytokines (14) . These multifunctional polypeptides are important in coordinating the host immune response to infection and tissue injury (14) . Previous studies reported increased concentrations of the cytokines T N F and IL-6 in amniotic fluid of women with preterm labor complicated by intraamniotic infection (15, 16) and in plasma of newborns with sepsis (17). Although functional IL-6 activity was not measured, IL-6 antigen concentrations were elevated on d 1 in lung lavage of intubated infants after PROM with or without neonatal sepsis (18). The major effects ascribed to IL-6 involve upregulation of the local immune response, but recent evidence demonstrating that direct intratracheal instillation of IL-6 abrogates subsequent lipopolysaccharide-induced lung injury suggests that IL-6 may also exert important antiinflammatory effects in the lung (19). This study and others (19-21) demonstrated that the antiinflammatory effects of IL-6 are caused, in part, by the inhibition of T N F synthesis and TNF-induced cytotoxicity. Because of this potential feedback interaction of T N F and IL-6, these two cytokines may be important modulators of the inflammatory response.
The goals of this study were 1) to determine whether the development of BPD is associated with changes in local pulmonary T N F and IL-6 during the first month of life and 2) to compare the activities and antigen concentrations of these cytokines in lung lavage from control infants without pulmonary disease, infants with selflimited RDS, and infants who develop BPD. Because the control and RDS infants were intubated for shorter periods than the BPD infants and only intubated infants could ethically be lavaged, comparisons among the three groups were limited to the first day of life. We measured functional activities and antigen concentrations of these cytokines in serially obtained lung lavage from 19 preterm infants who developed BPD, 11 infants with limited RDS, and 10 control infants. We proposed that, in the development of BPD, IL-6 and T N F interact to modulate a cascade of cell-to-cell signaling events involved in the inflammatory response. We hypothesized that differences in the activities of these cytokines may predispose some infants with RDS to develop BPD.
METHODS
Rabbit anti-human T N F antiserum was provided by Dr. Steven Kunkel (University of Michigan). Recombinant human IL-6 was expressed from plasmid pT7.71 hIL-6 in Escherichia coli BL21 (DE3) (American Type Culture Collection, Rockville, MD) and was purified by diethylaminoethanol-cellulose chromatography (22). Rabbit anti-human IL-6 antiserum was prepared by immunizing female New Zealand White rabbits (Hazelton, Hazelton, PA) with 500 bg of IL-6 in complete Freund's adjuvant S.C. and boosting with 500 pg of IL-6 i.v. 10 d before bleeding. Serum was collected from clotted blood by centrifugation and revealed three bands of 23 to 26 kD on Western blots of recombinant human IL-6. This antiserum neutralized the mitogenic activity of recombinant and natural IL-6 in the 7TD-1 bioassay.
Study population. Lung lavage was serially obtained from 30 premature infants admitted to the University of Maryland neonatal intensive care nursery who met the following criteria: 1) gestational age < 33 wk; 2) birth weight appropriate for gestational age; 3 ) requirement for mechanical ventilation on the first day of life for respiratory distress; 4) diagnosis of RDS confirmed radiographically; and 5) absence of documented infection or congenital lung abnormalities. Lung lavage was also obtained from 10 control infants who were intubated and mechanically ventilated for nonpulmonary reasons (apnea, 4; duodenal atresia, 1; abdominal wall defects, 3; and transposition of the great vessels, 2). The study protocol was approved by the institutional review board of the University of Maryland at Baltimore, and parental consent was obtained for each subject.
A subject was considered to have progressed to BPD if the infant developed the following: 1) required fraction of inspired oxygen > 0.21 on d 28 to maintain arterial Po, 2 6.65 kPa (50 mm Hg) (23) and 2) r stage Ill radiograph according to Northway's classification (24). Although the criterion of oxygen dependency at 28 d probably overestimates the diagnosis of BPD, an x-ray classification of r stage 111 BPD is strongly correlated with typical BPD lung pathology (25).
Lung lavage. Subjects' lungs were lavaged with two 1.0-mL aliquots of sterile saline using a standardized technique (13) on d 1,3,5,7, 14,21, and 28 as long as the infant remained intubated. While the infant was supine with the head midline, 1.0 mL of sterile saline was instilled endotracheally, three to five breaths were delivered with a Laerdal self-inflating resuscitation bag (Laerdal Medical Corp., Armonk, NY) or ventilator, the endotracheal tube was suctioned using a 6.5 or 8.0 French catheter, and the lavage was collected into a sputum trap. Suctioning was repeated with the head turned to one side and then the other. The procedure was repeated with a second 1.0-mL saline instillation. The suction catheter was rinsed with 0.5 mL of saline. The mean volume recovered from the lavage procedure was 0.58 -t 0.05 mL. Lavage samples were collected on d 1 between 10 and 24 h of life. The lavage samples were kept on ice until processed. Specimens were centrifuged at 2000 rpm for 10 min at 4°C. The supernatant was removed and stored at -70°C. Cells were counted using a hemacytometer, and cell viability was assessed by trypan blue dye exclusion. Cytospin preparations were made and stained with Diffquick (Baxter Healthcare Corp., McGraw Park, IL), and cell differentials were determined.
Pulmonary function. Serial pulmonary functions were determined using a computerized system (Pulmonary Evaluations and Diagnostic System; Medical Associated Services, Inc., Hatfield, PA) on the same days as the lung lavage. An esophageal balloon placed in the distal third of the esophagus was connected to a differential pressure transducer (Celesco P7D; Celesco Transducer Products, Inc., Canoga Park, CA). A pneumotachograph (Fleisch 00) was placed in the ventilatory expiratory circuit, and transpulmonary pressure and inspiratory and expiratory flow were measured. Tidal volume, dynamic compliance1 kg, and pulmonary resistance were calculated using the software of the Pulmonary Evaluations and Diagnostic System (26).
7TD-1 bioassay for ZL-6. Functional IL-6 activity was determined by measuring proliferation of the IL-6-dependent cell line 7TD-1 (27). Serial 2-fold dilutions of samples or recombinant human IL-6 were plated with 4 x lo3 7TD-1 cellslwell (American Type Culture Collection) in sterile 96-well flat-bottom microtiter plates (Costar, Cambridge, MA). After incubation for 72 h, cell viability was determined by metabolism of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma, St. Louis, MO) to a blue formazan product that was solubilized by incubation with 100 ~L l w e l l of a solution containing 20% (wtlvol) SDS in 50% N,N-dimethylformamide (Sigma), pH 4.7, for 2 h. The absorbance at 570 nm was measured using a microplate reader (Biotek Instruments, Winooski, VT). IL-6 activity was c'alculated from a standard curve using the Parlin data-fitting program and was expressed as hybridoma unitsll (28). In selected experiments, samples were preincubated with anti-IL-6 antiserum or preimmune serum for 1 h at room temperature before assay.
L929 bioassay for TNF. Functional T N F activity was determined by measuring cytotoxicity for TNF-sensitive L929 cells (29). L929 cells (American Type Culture Collection) were plated into 96-well flat-bottom microtiter plates (Costar) at a concentration of 6 x lo4 cellslwell in CRPMI/lO% newborn calf serum containing 1 &mL actinomycin D (Sigma). Serial 2-fold dilutions of samples or recombinant T N F standard (Genzyme Corp., Cambridge, MA) were added in triplicate to the plates. After 18 h of incubation at 37"C, the monolayers were washed, fixed with methanol, and stained with 0.1% crystal violet, and the absorbance at 540 nm was measured on a microtiter reader. One unit of T N F activity caused 50% lysis of L929 monolayers (29).
ELISA. ELISA for IL-6 and T N F were performed using commercially available kits purchased from Genzyme Corp. and Endogen (Boston, MA), respectively. These assays had sensitivities of 18 ng/L (IL-6) and 10 ng/L (TNF). For the IL-6 ELISA, the correlation coefficient of the linear regression of the standard curve was 0.99 and the intraassay and interassay coefficients of variation were 6.9 5 1.2 and 9.6 ? 1 .O, respectively. For the T N F ELISA, the correlation coefficient of the linear regression of the standard curve was 0.99, and the intraassay and interassay coefficients of variation were 6.0 ? 1.4 and 7.9 & 2.0, respectively. Protein determination. Total protein content of lung lavage samples was determined using bicinchoninic acid (Pierce Chemical Co., Rockford, IL).
Statistical analysis. Unless stated otherwise, data are expressed as the mean ? SD. Because there are no satisfactory reference denominators to normalize lung lavage data (30) (31) (32) (33) (34) and to compare results of this study with previous reports (6, 8, 9, 13) , lung lavage variables are expressed as concentration per volume. Although the secretory component of IgA has recently been suggested as an appropriate reference measurement to correct for dilutional effects of neonatal lung lavage (35, 36), it does not represent recovery from the alveolar compartment because it is not secreted by alveolar cells (37) and it has not been evaluated in normal newborn lungs (35, 36). Statistical analysis was performed using the Statview I1 statistical software package (Abacus Concepts, Inc., Berkeley, CA). Intragroup differences over time and intergroup variation for lung lavage variables were first determined by a one-way analysis of variance (28). Specific comparisons of lung lavage variables between groups were done using the Dunnett t test. Correlations were tested using linear regression analysis. A p value of <0.05 was considered significant.
RESULTS
Characteristics of the study population. Of the 30 premature infants with an initial diagnosis of RDS, 19 developed BPD according to study criteria. The clinical characteristics of the three groups are presented in Tables 1  and 2 . There were no statistically significant differences for birth weight or gestational age between the RDS and BPD groups, but the two groups of infants with lung disease were each of significantly lower birth weight and gestational age than the control group (Table 1) .
The sex and ethnic distributions of the three groups were similar. There were no differences in prenatal factors except for a higher incidence of preterm labor in the lung disease groups compared with controls (Table 2) . There was a significantly higher rate of vaginal delivery, surfactant therapy, and patent ductus arteriosus in the 30.1 d, control) . The BPD infants were exposed to supplemental oxygen and were hospitalized for significantly longer periods than the other groups (Table 1) .
Cytokine antigenic concentrations and functional activities in lung lavage. There were 149 samples collected from the 40 subjects with a mean number of samples per subject of 4 * 2. In 10 subjects, lavage was not obtained during the first 24 h because I ) the infant was not intubated on d 1 (one control), 2) the investigator was not available (n = 3), or 3) the infant was considered clinically too unstable for the lavage procedure (n = 6). Because lavage return was limiting, functional assays were performed first, and any residual fluid was assayed for antigen concentrations. There were 64 and 69 paired functional assays and antigen concentrations for IL-6 and TNF, respectively. There were 88 samples for which both IL-6 and TNF functional activities were measured. On the first day of life, IL-6 activity in lung lavage of infants who developed BPD was 15-fold and 6.6-fold higher compared with activities in lavage from control and RDS infants, respectively [control (n = 6), 49. by d 28. In the few subjects in the control and RDS groups in which lung lavage was analyzed after the first day of life, IL-6 activity remained low. IL-6 activity and antigen concentration were increased at 14 d in lavage samples from two RDS infants who were intubated for longer periods than the other infants in the RDS group for apnea (1) and sepsis (1). There were insufficient or unavailable samples from control and RDS infants for determination of IL-6 activity at 28 d. To confirm that functional activity was caused by IL-6, some samples of BPD lavage were pretreated with anti-IL-6 antiserum, which completely neutralized their activity in the 7TD1 assay (data not shown). In contrast to functional activity, antigenic concentrations of IL-6 were variable and not significantly different among groups on the first day of life (Table 3) . Functional T N F activity was undetectable in all control samples at all sample times and in the few available RDS samples from d 7 to 28 (Fig. 2) . In contrast, detectable but low activity was found in BPD samples from d 1 to d 28 with peak activity in d-14 samples (90.0 -t 40.6 x lo3 UIL, mean 2 SEM). T N F antigen concentrations did not differ significantly among groups on the first day of life. However, in the BPD group, T N F antigen concentrations were significantly higher on d 14 and d 28 compared with samples collected earlier @ < 0.05) ( Table 3) .
There were no differences among groups in the number of recovered cells in lavage (Table 3 ). Cell viability determined by trypan blue exclusion was 70.4 2 7.3%. Neutrophils were the predominant inflammatory cells in all groups for the first 3 d and remained the predominant cell in lavage from BPD infants 2 7 d. For the exogenous surfactant-treated infants, the lavage cell counts were higher on d 1 after Exosurf treatment compared with lavage cell counts after Survanta treatment (9.7 -t 6.9 x loh versus 2.6 2 1.6 x loh, p < 0.05). There were no apparent relationships between cell counts and IL-6 or T N F antigen concentrations or activities.
Protein concentration in lavage fluid remained fairly constant over time, and there were no significant differences among the groups (Table 3) . Normalization of lung lavage data for protein concentration did not affect differences in antigen concentration or functional activities of IL-6 or T N F (data not shown).
Because the control group was more mature with higher birth weights than the groups with lung disease, regression analyses were performed for the lavage variables with gestational age or birth weight as the dependent variable. T N F antigen concentrations were significantly correlated with gestational age on d 1 and 3 (d 1: r = 0 . 6 3 ,~ = 0.02; d 3: r = 0 . 8 5 ,~ = 0.0005) and with birth weight on d 3 (r = 0 . 8 3 ,~ = 0.0009; Table 4 ). However, T N F antigen concentrations on subsequent days were not significantly correlated with gestational age or birth weight. There were no significant correlations between T N F activity, IL-6 antigen concentration, or IL-6 activity and either gestational age or birth weight (Table 4) .
To determine whether abnormalities in functional IL-6 activity on d 1 were caused by differences in clinical variables, IL-6 activity and antigen concentration were correlated with prenatal factors (prolonged rupture of the membranes, chorioamnionitis), delivery route, presence or absence of a patent ductus arteriosus, exogenous surfactant therapy, and survival (Table 5) . Although there was a trend toward higher IL-6 activity and antigen concentration associated with chorioamnionitis, the differences were not significant. However, IL-6 activity was 3.7 times higher in lavage on d 1 in the two infants who died because of pulmonary-related causes compared with activities in lavage from all surviving infants (nonsurvi- On d 1 of life, there were no significant differences among groups for maximal ventilatory settings (fraction of inspired oxygen, peak inspiratory pressure, positive end expiratory pressure, and mean airway pressure), but the BPD infants had significantly lower dynamic compliance (5.3 f 0.5 mL/kPa/kg) than RDS infants or controls (9.3 2 2.2 and 7.8 2 1.9 mL/kPa/kg, respectively) consistent with more severe initial lung disease. The differences in dynamic compliance between RDS and control groups were not significant. As previously observed by other investigators (38, 39) , the BPD infants had persistently low compliance' and elevated resistance from d 7 through d 28. However, there were no correlations between ventilatory settings or pulmonary mechanics and cytokine activities or antigen concentrations. In the present study, functional IL-6 activity in lung lavage from infants who developed BPD was 15-fold and 6.6-fold higher than activities in lavage from controls and infants with self-limited RDS on the first day and remained elevated during the first 2 wk of life. In contrast to functional activity, there were no differences in antigenic IL-6 in d 1 lavage fluids among the BPD, RDS, and control groups (Table 3 ). The higher specific activity of IL-6 in d 1 lung lavage from the BPD group suggests that pathways for inactivating or inhibiting IL-6 (40) that may be present in the lungs of self-limited RDS and control patients may be deficient in patients who subsequently develop BPD. In addition, the lack of correlation be- tween antigen concentration and functional activity of IL-6 demonstrates the importance of measuring bioassays of cytokines in biologic fluids. Cytokine antigen may be detectable by ELISA, but the protein may be degraded or inactivated by bound inhibitors or soluble receptors (4043). In contrast to IL-6, T N F activity in lung lavage was low in all groups on d 1 but increased by d 14 of age in lavage of BPD infants. These findings suggest that differences in the activities of these cytokines, particularly IL-6, may be important in the regulation of lung inflammation and the pathogenesis of BPD. We speculate that the early increase in IL-6 activity in the BPD infants may be a response to the severity of the initial lung injury. In this study, there were technical limitations such as variable dilutional effects of the lavage procedure on assay measurements, availability of appropriate controls, and ethical concerns about lavaging healthy, nonintubated infants. For all assays, there were large standard deviations within groups. This most likely reflects biologic variability due to differences in severity of lung injury and differences in the complex host response, but dilutional effects of the lavage procedure may have contributed. Unfortunately, an appropriate reference denominator to correct for dilutional effects of lavage has not been described (30) (31) (32) (33) (34) . However, we doubt that the large differences in IL-6 activity among groups on d 1 can be explained by differential dilution. Inasmuch as the same volume was used for lavage in all subjects, a greater dilution should be expected for the smaller infants, which would minimize differences between the low birth weight BPD infants and the larger control infants, but higher IL-6 activities were measured in the BPD group than in the control group. Although it would be desirable to have control subjects with similar birth weight and gestational age as the study subjects, it would be unethical to intubate and lavage the lungs of healthy low-birth-weight infants for research purposes because of the serious risks of these procedures.
IL-6 is a multifunctional cytokine with both potential local and systemic effects (44) . It induces production of hepatic acute-phase reactant proteins, stimulates B cell differentiation and T cell activation (44) , and increases vascular permeability in vitro (45). IL-6 concentrations were elevated in amniotic fluid of women with preterm labor complicated by intraamniotic infection (15) . Recently, Grigg ef al. (18) reported an association of increased antigenic IL-6 concentrations in lung lavage of preterm infants on the first day of life and prolonged rupture of membranes. However, functional activity was not measured and the relationship of IL-6 to the development of BPD was not described (18). In the present study, we did not find significant differences in IL-6 activity or antigenic concentrations in lung lavage of infants from pregnancies complicated by chorioamnionitis compared with activity and levels in lavage of infants from pregnancies without clinical signs of chorioamnionitis (Table 5 ). The differences in study results may be caused, in part, by differences in study populations or by institutional differences in obstetrical management of PROM. For example, in our institution, maternal antibiotic prophylaxis is used commonly for PROM. Antibiotic therapy may suppress bacteria that induce cytokine release.
The source of IL-6 retrieved from the airways cannot be determined from this study. Potential sources include 1 ) lung cells (macrophages, fibroblasts, epithelial and endothelial cells), 2) alveolar leak of plasma proteins including cytokines, and 3) aspirated amniotic fluid. Although in vitro studies suggest that IL-6 production by cultured monocytes from preterm infants is depressed compared with synthesis by monocytes from term infants (18, 46, 47), other in vivo studies suggest that preterm infants are capable of IL-6 synthesis (17). Macrophages that were detected in lung lavage as early as d 1 in the infants with lung disease may be a source of the greatly elevated IL-6 activity found in BPD infant lavage on the first day of life. Because plasma samples were not obtained in this study, it is not possible to determine the relative contribution of locally released factors versus plasma-derived factors to the balance of cytokine activities. However, inasmuch as plasma levels of IL-6 are low in newborns in the absence of sepsis (48), it is unlikely that circulating IL-6 contributed significantly to the IL-6 levels in the lungs of these infants. The similar patterns of IL-6 expression in intraamniotic fluid in preterm labor and preterm infant lung lavage suggest a possible common pathway of cytokine involvement in initiating preterm labor and neonatal lung injury. Correlations of amniotic fluid IL-6 concentration and activity with infant lung lavage levels will be necessary to determine the relationship of cytokine-mediated labor and neonatal lung inflammation.
T N F antigen concentrations of samples from d 1 and 3, but not concentrations of samples from subsequent days, significantly correlated with gestational age and birth weight (Table 4) . This suggests that early T N F synthesis may be development dependent, but other factors affect T N F expression beyond the first few days of life. In contrast, T N F activity, as well as IL-6 antigen concentration and IL-6 activity did not correlate with either gestational age or birth weight. Therefore, the differences in IL-6 activity among groups were not caused solely by maturational differences.
T N F is a potent inducer of IL-6 expression by inflammatory and structural cells (49) (50) (51) (52) . IL-6 inhibits release of T N F by macrophages (21), thereby forming a negative feedback loop, which may limit inflammation. Intratracheal IL-6 blocked lipopolysaccharide-induced lung injury in rabbits (19). Soluble inhibitors of T N F (4143) and IL-6 (40) may further modulate the interaction between these cytokines by decreasing the availability of functional T N F or IL-6. In the BPD group, antigenic T N F levels were low on d 1 (Table 3 ) when IL-6 activity was highest (Fig. 1) . T N F levels subsequently rose in the BPD patients, with the highest levels from d 14 to d 28, when 
